Aclaris Therapeutics, Inc.
NASDAQ:ACRS
2.45 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 39.878 | 45.277 | 27.349 | 54.131 | 35.937 | 57.019 | 208.854 | 30.171 | 9.851 | 10.757 | 9.588 |
| Short Term Investments
| 79.228 | 172.294 | 164.065 | 32.068 | 39.078 | 110.953 | 173.655 | 107.051 | 75.017 | 5.373 | 3.736 |
| Cash and Short Term Investments
| 119.106 | 229.813 | 225.656 | 54.131 | 75.015 | 167.972 | 208.854 | 174.134 | 92.038 | 16.13 | 13.324 |
| Net Receivables
| 0.298 | 0.484 | 0.623 | 0.772 | 0.704 | 4.861 | 0.481 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -12.242 | -34.242 | 0 | 4.966 | 0.791 | -6.364 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 9.452 | 13.495 | 12.995 | 2.59 | 3.118 | 5.875 | 5.883 | 1.334 | 1.656 | 0.204 | 0.062 |
| Total Current Assets
| 128.856 | 231.55 | 205.032 | 57.493 | 83.803 | 179.499 | 208.854 | 174.134 | 92.038 | 16.334 | 13.386 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1.62 | 1.099 | 1.335 | 1.654 | 2.47 | 4.28 | 2.159 | 0.481 | 0.36 | 0.515 | 0.019 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 18.504 | 18.504 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0.269 | 6.973 | 7.048 | 7.123 | 7.199 | 72.951 | 7.349 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0.269 | 6.973 | 7.048 | 7.123 | 7.199 | 91.455 | 25.853 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 62.771 | 12.242 | 34.242 | 0 | 0 | 0 | 14.997 | 36.912 | 7.17 | 0.518 | 0.802 |
| Tax Assets
| 2.146 | 3.362 | 0 | 0 | 0 | 0 | -8.633 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.743 | -0.63 | 3.554 | 4.514 | 4.825 | 0.332 | 0.279 | -35.442 | -5.492 | 0.01 | 0 |
| Total Non-Current Assets
| 68.549 | 23.046 | 46.179 | 13.291 | 14.494 | 96.067 | 34.655 | 1.951 | 2.038 | 1.043 | 0.821 |
| Total Assets
| 197.405 | 254.596 | 251.211 | 70.784 | 98.297 | 275.566 | 243.509 | 176.085 | 94.076 | 17.377 | 14.207 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 8.878 | 10.351 | 9.985 | 5.254 | 9.917 | 14.755 | 7.822 | 2.845 | 0.81 | 1.263 | 0.353 |
| Short Term Debt
| 0.426 | 0.684 | 0.693 | 0.603 | 0.637 | 0.601 | 0.142 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 19.446 | 0 | 10.051 | 5.906 | 7.721 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.202 | 10.903 | 2.202 | 3.111 | 4.157 | 11.986 | 4.798 | 3.378 | 0.745 | 0.188 | 0.014 |
| Total Current Liabilities
| 30.952 | 21.938 | 22.931 | 14.874 | 22.432 | 27.342 | 12.762 | 6.223 | 1.555 | 1.451 | 0.367 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 3.074 | 1.57 | 2.172 | 10.653 | 3.569 | 29.914 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| -3.074 | -1.57 | -2.172 | 0 | -3.569 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.146 | 0.367 | 0.367 | 0.367 | 0.549 | 0.549 | 0.549 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.128 | 34.67 | 30.572 | 7.24 | 5.404 | 2.637 | 4.936 | 0.372 | 0 | 36.681 | 23.003 |
| Total Non-Current Liabilities
| 9.274 | 35.037 | 30.939 | 18.26 | 5.953 | 33.1 | 5.485 | 0.372 | 0 | 36.681 | 23.003 |
| Total Liabilities
| 40.226 | 56.975 | 53.87 | 33.134 | 28.385 | 60.442 | 18.247 | 6.595 | 1.555 | 38.132 | 23.37 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 94.076 | 36.677 | 23 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -770.796 | -682.315 | -595.407 | -504.542 | -453.527 | -292.173 | -159.435 | -90.912 | -42.833 | -20.749 | -9.166 |
| Accumulated Other Comprehensive Income/Loss
| -0.106 | -0.897 | -0.224 | -0.094 | -0.066 | -0.069 | -0.246 | -0.269 | -0.149 | -0.006 | 0.003 |
| Other Total Stockholders Equity
| 928.08 | 880.832 | 792.971 | 542.286 | 523.505 | 507.366 | 384.943 | 260.671 | 41.427 | -36.677 | -23 |
| Total Shareholders Equity
| 157.179 | 197.621 | 197.341 | 37.65 | 69.912 | 215.124 | 225.262 | 169.49 | 92.521 | -20.755 | -9.163 |
| Total Equity
| 157.179 | 197.621 | 197.341 | 37.65 | 69.912 | 215.124 | 225.262 | 169.49 | 92.521 | -20.755 | -9.163 |
| Total Liabilities & Shareholders Equity
| 197.405 | 254.596 | 251.211 | 70.784 | 98.297 | 275.566 | 243.509 | 176.085 | 94.076 | 17.377 | 14.207 |